Health Populi

JULY 1, 2020

health systems are projected to lose $323 billion in 2020 due to declining inpatient and outpatient volumes caused by the COVID-19 pandemic’s impact on the “normal” hospital business. Some hospitals in regions of these states are approaching full capacity in ICUs and COVID units. fall in outpatient volume.

Hospitals 124

Hospitals COVID-19 Pharmaceutical Industry Doctors 124

HIT Consultant

AUGUST 18, 2021

The pandemic has given rise to new norms in drug development that will influence the future of the industry as we know it. The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools. Here’s a look at what we’ve learned from COVID-19 era regulatory practices in clinical development.

COVID-19 52

COVID-19 COVID-19 Vaccine Pharmaceutical Industry FDA 52

HIT Consultant

AUGUST 29, 2021

In the Pharmaceutical industry, one of the major gaps is an effective, and personalized customer experience. . The COVID-19 pandemic drastically affected the way consumers prefer to receive medication and medical services. pharmaceutical industry will be worth $ 685.45 Adopting and Leveraging Technology.

Pharmaceutical Industry 98

Pharmaceutical Industry COVID-19 Telemedicine Doctors 98

HIT Consultant

MAY 2, 2022

The FDA is attempting to address this, having issued guidelines related to diversity in clinical trials in November 2020 – perhaps prompted by widespread media coverage of the fact that the black members of the society and other people of color were underrepresented in clinical trials for COVID-19 vaccines.

COVID-19 Vaccine 98

COVID-19 Vaccine Patient Advocacy Pharmaceutical Industry Health Outcomes 98

Bill of Health

AUGUST 29, 2022

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”

COVID-19 Vaccine 362

COVID-19 Vaccine COVID-19 Licensing Governance 362

HIT Consultant

MAY 25, 2022

A recent report from the National Institutes of Health projected spending on specialty drugs to outpace growth in the pharmaceutical market, enough to exceed 50 percent of overall drug expenditures in 2021. These drugs bring the promise of positive clinical outcomes where they are most needed, so expanding access to them is imperative.

COVID-19 Vaccine 98

COVID-19 Vaccine Medical Billing Medical Device Industry Pharmaceutical Industry 98

HIT Consultant

NOVEMBER 17, 2021

As with countless global industries, clinical trials were forced to move key functions online as COVID-19 swept the world in early 2020. Further underscoring this trend, 93% of sites also reported that they would allow sponsors or CROs to conduct remote monitoring, compared to 74% pre-COVID. About Robert Geckeler.

COVID-19 97

COVID-19 Pharmaceutical Industry Informed Consent Compliance 97

Bill of Health

SEPTEMBER 28, 2023

By Nikhil Chaudhry and Reshma Ramachandran Earlier this month, the Department of Health and Human Services announced that it had successfully included a reasonable pricing provision in a $326M investment contract with Regeneron for development of a next generation monoclonal antibody therapy for COVID-19. pharmaceutical market.

COVID-19 205

COVID-19 COVID-19 Vaccine Pharmaceutical Industry Governance 205

HIT Consultant

DECEMBER 18, 2023

Artificial Intelligence as a “Smart” Assistant for Doctors Medical chatbots have proven their necessity during the COVID-19 outbreak. About Natalie Tkachenko , Healthcare Software Solutions Consultant at NIX Natalie is a HIPAA-certified expert with high-grade knowledge in the healthcare and pharmaceutical industries.

Electronic Medical Records 105

Electronic Medical Records Doctors HIPAA Pharmaceutical Industry 105

Healthcare IT Today

DECEMBER 15, 2023

About Natalie Tkachenko Natalie is a HIPAA-certified expert with high-grade knowledge in the healthcare and pharmaceutical industries. Only on the Microsoft platform, more than a thousand chatbots were created during the pandemic. Today, there is a technical solution for every such need.

Electronic Medical Records 106

Electronic Medical Records Doctors HIPAA Hospitals 106

Health Populi

MARCH 11, 2021

have struggled to pay for living expenses since December 2020, a year into the COVID-19 pandemic. To that point, consider the March 2021 Kaiser Family Foundation Health Tracking Poll which learned that over one in three people in the U.S.

Health Insurance 98

Health Insurance ACA Medicare Medicare 98

Bill of Health

MAY 5, 2023

The COVID-19 crisis demonstrated how the need for protecting and incentivizing innovation clashed with the need to make products widely available. To solve this tension, the Commission recognizes that patent law already offers a solution: compulsory licensing. For example, the U.S.

Licensing 285

Licensing Pharmaceutical Industry Governance COVID-19 285

Health Law Advisor

AUGUST 11, 2022

How has COVID-19 impacted these efforts? In this episode of the Diagnosing Health Care Podcast : For years, pharmacy advocates have urged policymakers to make changes to state scope of practice laws that would permit pharmacists to prescribe and administer certain tests and vaccines at the pharmacy.

COVID-19 52

COVID-19 Pharmaceutical Industry 52

Hall Render

FEBRUARY 18, 2022

CMS may now enforce its COVID-19 vaccination policy for healthcare workers in all 50 states. HHS seeks $30B to combat COVID-19. As Alabama COVID numbers fall, ICUs across the state remained slammed. Doctors: Pediatric COVID cases appear to be trending down. Million in Covid Relief. CALIFORNIA.

COVID-19 40

COVID-19 Nursing Homes Nurses COVID-19 Vaccine 40

Bill of Health

SEPTEMBER 12, 2023

JRJ: Now, looking to the future of pharmaceutical regulation, the FDA approval of Opill is a significant milestone, from a legal or regulatory perspective. Do you think that this recent approval changes the calculus for future drug approvals or regulations of the pharmaceutical industry, or for people seeking this form of care?

FDA 184

FDA Pharmaceutical Industry COVID-19 Public Health 184

HIT Consultant

DECEMBER 1, 2021

Telemedicine use grew more than 6,000 percent during the COVID-19 pandemic and experts estimate that the pandemic drove 10 years’ worth of telemedicine innovations in roughly 12 months. He has built several research-based businesses focused on providing the highest quality and most timely data in information-intensive industries.

COVID-19 98

COVID-19 Telemedicine Pharmaceutical Industry Patient Satisfaction 98

Dot Compliance

FEBRUARY 1, 2022

The global pharmaceutical industry has seen its share of challenges in recent years, from manufacturing and supply chain bottlenecks to growing demand for faster delivery of drugs to the marketplace. The next evolution is for companies to implement Industry 4.0 What will the near future bring to the table?

FDA 52

FDA COVID-19 Vaccine Pharmaceutical Industry COVID-19 52

SQA

AUGUST 2, 2021

COVID-19 Response: Freely Available ISO Standards, 18 June 2021. A number of ISO standards have been made available to support global efforts to address the COVID-19 crisis. It also offers an examination of the technologies available for package integrity testing not yet established by peer-reviewed research.

FDA 83

FDA COVID-19 Pharmaceutical Industry Hospitals 83

Hall Render

APRIL 21, 2023

health-tech startup MemoryWell pivots, eyes new funding to roll out software for insurers Department of Veterans Affairs health system kicks off multiyear Greater Washington expansion Georgetown to open Southeast D.C.

US Department of Health and Human Services 40

US Department of Health and Human Services COVID-19 Nurses Nursing Homes 40

SQA

FEBRUARY 26, 2024

It provides a practical guide for the pharmaceutical industry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines. Recommendations for stability studies.

FDA 52

FDA Compliance COVID-19 Public Health 52

Health Populi

MARCH 23, 2021

A year into the COVID-19 pandemic, most Americans are still in “survival mode,” according to an update of the 2021 Edelman Trust Barometer, Trust and the Coronavirus in the U.S. consumers was the pharmaceutical industry, increasing by 8 points. among 2,500 people in early March.

COVID-19 91

COVID-19 Doctors Public Health Pharmaceutical Industry 91

Health Populi

FEBRUARY 22, 2021

The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. consumers trusted the biotech health industry segment compared with the pharmaceutical segment.

COVID-19 154

COVID-19 COVID-19 Vaccine Pharmaceutical Industry Public Health 154

Health Populi

SEPTEMBER 17, 2023

I can’t help hearing Paul Simon’s lyrics to Slip Slidin’ Away … ”you know the nearer your destination, the more you’re slip slidin’ away” when it comes to health citizens’ perceptions of pharma and the healthcare industry. consumers deal with.

Pharmaceutical Industry 68

Pharmaceutical Industry COVID-19 Medicare Medicare 68

Health Populi

APRIL 2, 2021

cannot afford to pay for quality health care — an especially acute challenge for Black and Hispanic Americans, according to a West Health-Gallup poll conducted in March 2021, a year into the COVID-19 pandemic. One in five people in the U.S. Clearly, people earning lower incomes have less to spend on goods and services.

COVID-19 77

COVID-19 ACA Medicare Medicare 77

Health Populi

APRIL 27, 2023

The COVID-19 pandemic re-shaped European Union leaders to reimagine healthcare, public health, and health citizenship in the EU. On 26th April 2023, the EC unveiled the most significant reforms for the region’s pharmaceutical industry in twenty years.

Pharmaceutical Industry 62

Pharmaceutical Industry Public Health COVID-19 Governance 62